Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity
Vivian Weiwen Xue, Jeff Yat‐Fai Chung, Cristina Alexandra García Córdoba, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 331
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
Jeff Yat‐Fai Chung, Max Kam‐Kwan Chan, Jane Siu-Fan Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7575-7575
Open Access | Times Cited: 129
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
The role of tumor-associated macrophages in tumor immune evasion
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation
Mohammad Yasin Zamanian, Hashem O. Alsaab, Maryam Golmohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 16
ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition
Yuexian Li, Cheng Sun, Yonggang Tan, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 2, pp. 635-650
Open Access | Times Cited: 63
TGF-β signaling networks in the tumor microenvironment
Max Kam‐Kwan Chan, Jeff Yat‐Fai Chung, Philip Chiu‐Tsun Tang, et al.
Cancer Letters (2022) Vol. 550, pp. 215925-215925
Closed Access | Times Cited: 48
Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain
Philip Chiu‐Tsun Tang, Jeff Yat‐Fai Chung, Jinyue Liao, et al.
Science Advances (2022) Vol. 8, Iss. 40
Open Access | Times Cited: 45
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
Pan Zhang, Chao Qin, Nan Liu, et al.
Biomaterials (2022) Vol. 284, pp. 121518-121518
Closed Access | Times Cited: 40
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer
Jiaqi Huang, Qianqian Yin, Yuqing Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 10
Pollutants to pathogens: The role of heavy metals in modulating TGF-β signaling and lung cancer risk
Asif Ahmad Bhat, Ehssan Moglad, Pooja Bansal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155260-155260
Closed Access | Times Cited: 9
Integrated analysis of non‑coding RNAs (HOTAIR and miR‑130a) and their cross‑talk with TGF‑β1, SIRT1 and E‑cadherin as potential biomarkers in colorectal cancer
Ghada Ayeldeen, Bahaa Badr, Olfat Shaker, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer
Ana K. Herrera-Vargas, Eduardo García-Rodríguez, Monserrat Olea‐Flores, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 62, pp. 23-41
Closed Access | Times Cited: 47
A Bibliometric Analysis Based on Web of Science: Current Perspectives and Potential Trends of SMAD7 in Oncology
Xueying Huang, Zhiying Yang, Jinning Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 35
Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β
Leah Alabanza, Ying Xiong, Bang K. Vu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Max Kam‐Kwan Chan, Emily Lok-Yiu Chan, Zoey Zeyuan Ji, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 316-343
Open Access | Times Cited: 19
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
Chao Yang, Dan Li, Chung‐Nga Ko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology
Marcin Szymański, Klaudia Bonowicz, Paulina Antosik, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 836-836
Open Access | Times Cited: 6
The immune regulation and therapeutic potential of the SMAD gene family in breast cancer
Zhuo Chen, Yu Wang, Xiaodi Lu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
Jia-Han Ding, Yi Xiao, Shen Zhao, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 624-635
Open Access | Times Cited: 26
Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease
Yuan Sui, Shuping Li, Xueqi Fu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy
Víctor H. Villar, Tijana Subotički, Dragoslava Đikić, et al.
Advances in experimental medicine and biology (2023), pp. 309-328
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top